131 related articles for article (PubMed ID: 226443)
1. A malignant insulinoma transformed into a glucagonoma syndrome.
Ohneda A; Otsuki M; Fujiya H; Yaginuma N; Kokubo T; Ohtani H
Diabetes; 1979 Nov; 28(11):962-9. PubMed ID: 226443
[No Abstract] [Full Text] [Related]
2. Streptozotocin effective for treating multiple-hormone-producing malignant islet cell tumor.
Murata E; Tashiro S; Hiraoka T
Jpn J Surg; 1985 Jan; 15(1):63-7. PubMed ID: 2985854
[TBL] [Abstract][Full Text] [Related]
3. Use of somatostatin and somatostatin analogs in a patient with a glucagonoma.
Kahn CR; Bhathena SJ; Recant L; Rivier J
J Clin Endocrinol Metab; 1981 Sep; 53(3):543-9. PubMed ID: 6114963
[No Abstract] [Full Text] [Related]
4. Insulin and C-peptide in plasma and tumor of insulinoma patients.
Ohneda A; Sakai T; Kobayashi T; Nihei J
Tohoku J Exp Med; 1983 Jan; 139(1):73-81. PubMed ID: 6301101
[No Abstract] [Full Text] [Related]
5. Metabolic studies and glucagon gel filtration pattern before and after surgery in a case of glucagonoma syndrome.
von Schenck H; Thorell JI; Berg J; Bojs G; Dymling JF; Hallengren B; Ljungberg O; Tibblin S
Acta Med Scand; 1979; 205(3):155-62. PubMed ID: 218426
[TBL] [Abstract][Full Text] [Related]
6. Glucagonoma syndrome. Report of two cases and literature review.
Binnick AN; Spencer SK; Dennison WL; Horton ES
Arch Dermatol; 1977 Jun; 113(6):749-54. PubMed ID: 194536
[TBL] [Abstract][Full Text] [Related]
7. Effects of somatostatin on insulin and glucagon in patients with insulinoma.
Fallucca F; Mirabella C; Tamburrano G; Gambardella S; Aufieri G; Barbetti F; Andreani D
J Endocrinol Invest; 1979; 2(3):257-60. PubMed ID: 231062
[TBL] [Abstract][Full Text] [Related]
8. A case with glucagonoma syndrome--endocrine and metabolic studies.
Fukushima H; Yamaguchi K; Uzawa H; Kitoh M; Takemiya M; Konno T
Endocrinol Jpn; 1981 Apr; 28(2):111-25. PubMed ID: 6273136
[TBL] [Abstract][Full Text] [Related]
9. Glucagon-secreting pancreatic islet cell carcinoma, containing insulin and somatostatin, with hypoglycemic attack.
Yano T; Yamamoto N; Fujimori K; Inamori S; Hayashi H; Mizumoto R
Am J Gastroenterol; 1982 Jun; 77(6):387-91. PubMed ID: 6124121
[TBL] [Abstract][Full Text] [Related]
10. Improvement of metastatic endocrine tumors of the pancreas by hepatic artery chemoembolization.
Nesović M; Cirić J; Radojković S; Zarković M; Durović M
J Endocrinol Invest; 1992; 15(7):543-7. PubMed ID: 1447492
[TBL] [Abstract][Full Text] [Related]
11. Malignant glucagonoma syndrome: response to chemotherapy.
Marynick SP; Fagadau WR; Duncan LA
Ann Intern Med; 1980 Sep; 93(3):453-4. PubMed ID: 6254416
[TBL] [Abstract][Full Text] [Related]
12. A familial glucagonoma syndrome: genetic, clinical and biochemical features.
Stacpoole PW; Jaspan J; Kasselberg AG; Halter SA; Polonsky K; Gluck FW; Liljenquist JE; Rabin D
Am J Med; 1981 May; 70(5):1017-26. PubMed ID: 6112877
[TBL] [Abstract][Full Text] [Related]
13. Glucagonoma tumors and syndrome.
Montenegro-Rodas F; Samaan NA
Curr Probl Cancer; 1981 Dec; 6(6):1-54. PubMed ID: 6276079
[No Abstract] [Full Text] [Related]
14. Malignant metastatic insulinoma treated with streptozotocin.
Gefel A; Flatau E; Ayalon D; Papo J; Loewenthal M
Clin Endocrinol (Oxf); 1975 Sep; 4(5):461-8. PubMed ID: 170028
[TBL] [Abstract][Full Text] [Related]
15. Somatostatin analogue in treatment of coexisting glucagonoma and pancreatic pseudocyst: dissociation of responses.
Moattari AR; Cho K; Vinik AI
Surgery; 1990 Sep; 108(3):581-7. PubMed ID: 2168587
[TBL] [Abstract][Full Text] [Related]
16. An islet cell carcinoma containing glucagon and insulin. Chronic glucagon excess and glucose homeostasis.
Boden G; Owen OE; Rezvani I; Elfenbein BI; Quickel KE
Diabetes; 1977 Feb; 26(2):128-37. PubMed ID: 190071
[TBL] [Abstract][Full Text] [Related]
17. Hormonal responses to intravenous and oral glucose tolerance testing in a patient with a gastrinoma and a gastrojejunostomy.
Massaro RP
Gastroenterology; 1974 May; 66(5):1058-62. PubMed ID: 4363772
[No Abstract] [Full Text] [Related]
18. Malignant insulinoma: effects of a somatostatin analog (compound 201-995) on serum glucose, growth, and gastro-entero-pancreatic hormones.
Osei K; O'Dorisio TM
Ann Intern Med; 1985 Aug; 103(2):223-5. PubMed ID: 2861769
[No Abstract] [Full Text] [Related]
19. Glucagon secretion during the development of insulin-secreting tumors induced by streptozotocin and nicotinamide.
Yoshino G; Kazumi T; Morita S; Kobayashi N; Terashi K; Baba S
Endocrinol Jpn; 1979 Dec; 26(6):655-60. PubMed ID: 232037
[TBL] [Abstract][Full Text] [Related]
20. [Zollinger-Ellison syndrome and metastatic insulinoma; its response to streptozotocin].
Agular-Parada E; Rivadeneyra-Hinojosa J; Guzman-Patraca C; Salas-Montero J; Escalante-Herrera A
Arch Invest Med (Mex); 1977; 8(1):31-8. PubMed ID: 192163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
